Assets:
|
|
|
|
Investments in unaffiliated securities, at value
(cost$145,647,024)
1
|
$
|
161,283,375
|
|
Investment in affiliated security, at value
(cost$4,915,379)
|
|
4,915,379
|
|
Repurchase agreement, at value
(cost$98,373,000)
|
|
98,373,000
|
|
Total investments in securities, at value
(cost$248,935,403)
|
$
|
264,571,754
|
|
Cash
|
|
138,561
|
|
Cash collateral on futures
|
|
3,294,623
|
|
Receivable for investments sold
|
|
10,604,895
|
|
Receivable for shares of beneficial interest
sold
|
|
5,533
|
|
Receivable for dividends and interest
|
|
650,070
|
|
Receivable for variation margin on futures
contracts
|
|
592,797
|
|
Receivable for foreign tax reclaims
|
|
242
|
|
Other assets
|
|
24,438
|
|
Total assets
|
|
279,882,913
|
|
Liabilities:
|
|
|
|
Payable for investments purchased
|
|
19,412,646
|
|
Payable for cash collateral from securities
loaned
|
|
4,915,379
|
|
Payable for shares of beneficial interest
repurchased
|
|
374,460
|
|
Payable to affiliates
|
|
205,548
|
|
Payable for foreign withholding taxes
|
|
700
|
|
Accrued expenses and other liabilities
|
|
154,298
|
|
Total liabilities
|
|
25,063,031
|
|
Net assets:
|
|
|
|
Beneficial interest shares of $0.001 par value
(unlimited amount authorized)
|
|
317,448,690
|
|
Accumulated undistributed net investment
income
|
|
975,414
|
|
Accumulated net realized loss
|
|
(79,830,112
|
)
|
Net unrealized appreciation
|
|
16,225,890
|
|
Net assets
|
$
|
254,819,882
|
|
Class A
|
|
|
|
Net assets
|
$
|
167,031,119
|
|
Shares outstanding
|
|
4,934,214
|
|
Net asset value per share
|
$
|
33.85
|
|
Maximum offering price per share (net asset value
plus maximum sales charge of 5.50%)
|
$
|
35.82
|
|
Class C
|
|
|
|
Net assets
|
$
|
68,734,872
|
|
Shares outstanding
|
|
2,071,910
|
|
Net asset value and offering price per
share
|
$
|
33.17
|
|
Class Y
|
|
|
|
Net assets
|
$
|
19,053,891
|
|
Shares outstanding
|
|
555,105
|
|
Net asset value and offering price per
share
|
$
|
34.32
|
|
1
Includes $6,224,158, of
investments in securities on loan, at value plus accrued interest and dividends,
if any.
26
|
See accompanying notes to
financial statements
|
UBS U.S. Allocation Fund
Statement of operations
|
For the year
ended
August 31, 2013
|
Investment
income:
|
|
|
|
|
|
Dividends (net of foreign withholding taxes of
$2,542)
|
|
$
|
1,652,870
|
|
|
Interest (net of foreign withholding taxes of
$9)
|
|
|
2,275,960
|
|
|
Securities lending income (includes $2,250 earned
from an affiliated entity)
|
|
|
33,852
|
|
|
|
|
|
3,962,682
|
|
|
Expenses:
|
|
|
|
|
|
Investment management and administration
fees
|
|
|
1,288,607
|
|
|
Service feesClass A
|
|
|
424,755
|
|
|
Service and distribution feesClass C
|
|
|
697,337
|
|
|
Transfer agency and related services feesClass
A
|
|
|
172,512
|
|
|
Transfer agency and related services feesClass
C
|
|
|
76,875
|
|
|
Transfer agency and related services feesClass
Y
|
|
|
13,369
|
|
|
Professional fees
|
|
|
178,234
|
|
|
Custody and accounting fees
|
|
|
107,663
|
|
|
Reports and notices to shareholders
|
|
|
76,371
|
|
|
State registration fees
|
|
|
49,238
|
|
|
Trustees fees
|
|
|
16,185
|
|
|
Insurance expense
|
|
|
5,689
|
|
|
Other expenses
|
|
|
25,577
|
|
|
Total expenses
|
|
|
3,132,412
|
|
|
Net investment income
|
|
|
830,270
|
|
|
Net realized and unrealized
gains (losses)
|
|
|
|
|
|
from investment
activities:
|
|
|
|
|
|
Net realized
gains from:
|
|
|
|
|
|
Investments in unaffiliated issuers
|
|
|
21,191,476
|
|
|
Investment in affiliated issuer
|
|
|
1,793,352
|
|
|
Futures
|
|
|
6,874,951
|
|
|
Swaps
|
|
|
352,272
|
|
|
Net realized gain
|
|
|
30,212,051
|
|
|
Net change in
unrealized appreciation/depreciation of:
|
|
|
|
|
|
Investments in unaffiliated issuers
|
|
|
1,767,180
|
|
|
Investment in affiliated issuer
|
|
|
(2,039,611
|
)
|
|
Futures
|
|
|
70,214
|
|
|
Swaps
|
|
|
31,867
|
|
|
Net change in unrealized
appreciation/depreciation
|
|
|
(170,350
|
)
|
|
Net realized and unrealized gain from investment
activities
|
|
|
30,041,701
|
|
|
Net increase in net assets resulting from
operations
|
|
$
|
30,871,971
|
|
|
See accompanying notes to
financial statements
|
27
|
UBS U.S. Allocation Fund
Statement of changes in net
assets
|
For the years ended August
31,
|
|
2013
|
|
2012
|
From
operations:
|
|
|
|
|
|
|
|
Net investment income
|
$
|
830,270
|
|
|
$
|
920,589
|
|
Net realized gains
|
|
30,212,051
|
|
|
|
13,731,479
|
|
Net change in unrealized appreciation/depreciation
|
|
(170,350
|
)
|
|
|
13,758,648
|
|
Net increase in net assets resulting
from operations
|
|
30,871,971
|
|
|
|
28,410,716
|
|
Dividends to shareholders
from:
|
|
|
|
|
|
|
|
Net investment incomeClass A
|
|
(857,187
|
)
|
|
|
(1,853,059
|
)
|
Net investment incomeClass C
|
|
|
|
|
|
(166,185
|
)
|
Net investment incomeClass Y
|
|
(139,744
|
)
|
|
|
(259,667
|
)
|
Total dividends to shareholders
|
|
(996,931
|
)
|
|
|
(2,278,911
|
)
|
From beneficial interest
transactions:
|
|
|
|
|
|
|
|
Net proceeds from shares sold
|
|
1,880,508
|
|
|
|
4,392,621
|
|
Cost of shares repurchased
|
|
(40,189,217
|
)
|
|
|
(44,535,126
|
)
|
Proceeds from dividends reinvested
|
|
906,535
|
|
|
|
2,065,080
|
|
Net decrease in net assets from
beneficial interest transactions
|
|
(37,402,174
|
)
|
|
|
(38,077,425
|
)
|
Redemption fees
|
|
2,877
|
|
|
|
511
|
|
Net decrease in net assets
|
|
(7,524,257
|
)
|
|
|
(11,945,109
|
)
|
Net assets:
|
|
|
|
|
|
|
|
Beginning of year
|
|
262,344,139
|
|
|
|
274,289,248
|
|
End of year
|
$
|
254,819,882
|
|
|
$
|
262,344,139
|
|
Accumulated undistributed net
investment income
|
$
|
975,414
|
|
|
$
|
1,009,006
|
|
28
|
See accompanying notes to financial
statements
|
UBS U.S. Allocation Fund
Financial highlights
Selected data for a share of
beneficial interest outstanding throughout each year is presented
below:
|
|
Class A
|
|
|
Years ended August 31,
|
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
Net asset value, beginning
of year
|
|
$30.13
|
|
|
$27.34
|
|
|
$24.16
|
|
|
$22.96
|
|
|
$28.83
|
|
Net investment income
1
|
|
0.16
|
|
|
0.15
|
|
|
0.25
|
|
|
0.32
|
|
|
0.46
|
|
Net realized and unrealized gains (losses)
|
|
3.72
|
|
|
2.94
|
|
|
3.34
|
|
|
1.47
|
|
|
(5.65
|
)
|
Net increase (decrease) from operations
|
|
3.88
|
|
|
3.09
|
|
|
3.59
|
|
|
1.79
|
|
|
(5.19
|
)
|
Dividends from net investment income
|
|
(0.16
|
)
|
|
(0.30
|
)
|
|
(0.41
|
)
|
|
(0.59
|
)
|
|
(0.68
|
)
|
Net asset value, end of year
|
|
$33.85
|
|
|
$30.13
|
|
|
$27.34
|
|
|
$24.16
|
|
|
$22.96
|
|
Total investment
return
2
|
|
12.92
|
%
|
|
11.42
|
%
|
|
14.85
|
%
|
|
7.75
|
%
|
|
(17.49
|
)%
|
Ratios to average net assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses before fee waivers
|
|
1.03
|
%
|
|
1.03
|
%
|
|
1.02
|
%
|
|
1.03
|
%
|
|
1.05
|
%
|
Expenses after fee waivers
|
|
1.03
|
%
|
|
1.03
|
%
|
|
1.02
|
%
|
|
1.03
|
%
|
|
1.05
|
%
|
Net investment income
|
|
0.51
|
%
|
|
0.53
|
%
|
|
0.92
|
%
|
|
1.30
|
%
|
|
2.26
|
%
|
Supplemental data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets, end of year (000s)
|
|
$167,031
|
|
|
$173,218
|
|
|
$178,780
|
|
|
$190,007
|
|
|
$221,983
|
|
Portfolio turnover
|
|
148
|
%
|
|
150
|
%
|
|
157
|
%
|
|
138
|
%
|
|
111
|
%
|
1
Calculated using the
average shares method.
|
2
Total investment
return is calculated assuming a $10,000 investment on the first day of
each year reported, reinvestment of all dividends and other distributions,
if any, at net asset value on the ex-dividend dates, and a sale at net
asset value on the last day of each year reported. The figures do not
include any applicable sales charges or redemption fees; results would be
lower if they were included. Returns do not reflect the deduction of taxes
that a shareholder would pay on Fund distributions or the redemption of
Fund shares.
|
See accompanying notes to financial
statements
|
29
|
UBS U.S. Allocation Fund
Financial highlights
Selected data for a share of
beneficial interest outstanding throughout each year is presented
below:
|
|
Class C
|
|
|
Years ended August
31,
|
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
Net asset value, beginning
of year
|
|
$29.60
|
|
|
$26.83
|
|
|
$23.70
|
|
|
$22.55
|
|
|
$28.19
|
|
Net investment income (loss)
1
|
|
(0.08
|
)
|
|
(0.06
|
)
|
|
0.04
|
|
|
0.13
|
|
|
0.30
|
|
Net realized and unrealized gains
(losses)
|
|
3.65
|
|
|
2.89
|
|
|
3.28
|
|
|
1.43
|
|
|
(5.50
|
)
|
Net increase (decrease) from operations
|
|
3.57
|
|
|
2.83
|
|
|
3.32
|
|
|
1.56
|
|
|
(5.20
|
)
|
Dividends from net investment
income
|
|
|
|
|
(0.06
|
)
|
|
(0.19
|
)
|
|
(0.41
|
)
|
|
(0.44
|
)
|
Net asset value, end of year
|
|
$33.17
|
|
|
$29.60
|
|
|
$26.83
|
|
|
$23.70
|
|
|
$22.55
|
|
Total investment
return
2
|
|
12.06
|
%
|
|
10.59
|
%
|
|
14.00
|
%
|
|
6.90
|
%
|
|
(18.10
|
)%
|
Ratios to average net assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses before fee waivers
|
|
1.79
|
%
|
|
1.79
|
%
|
|
1.77
|
%
|
|
1.78
|
%
|
|
1.80
|
%
|
Expenses after fee waivers
|
|
1.79
|
%
|
|
1.79
|
%
|
|
1.77
|
%
|
|
1.78
|
%
|
|
1.80
|
%
|
Net investment income (loss)
|
|
(0.25
|
)%
|
|
(0.23
|
)%
|
|
0.16
|
%
|
|
0.55
|
%
|
|
1.51
|
%
|
Supplemental data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets, end of year
(000s)
|
|
$68,735
|
|
|
$70,215
|
|
|
$74,702
|
|
|
$79,561
|
|
|
$94,818
|
|
Portfolio turnover
|
|
148
|
%
|
|
150
|
%
|
|
157
|
%
|
|
138
|
%
|
|
111
|
%
|
1
Calculated using the
average shares method.
|
2
Total investment return
is calculated assuming a $10,000 investment on the first day of each year
reported, reinvestment of all dividends and other distributions, if any, at net
asset value on the ex-dividend dates, and a sale at net asset value on the last
day of each year reported. The figures do not include any applicable sales
charges or redemption fees; results would be lower if they were included.
Returns do not reflect the deduction of taxes that a shareholder would pay on
Fund distributions or the redemption of Fund shares.
|
30
|
See accompanying notes to
financial statements
|
UBS U.S. Allocation Fund
Financial highlights
Selected data for a share of
beneficial interest outstanding throughout each year is presented
below:
|
|
Class Y
|
|
|
Years ended August 31,
|
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
|
2009
|
Net asset value, beginning
of year
|
|
$30.54
|
|
|
$27.72
|
|
|
$24.51
|
|
|
$23.29
|
|
|
$29.27
|
|
Net investment income
1
|
|
0.26
|
|
|
0.24
|
|
|
0.34
|
|
|
0.41
|
|
|
0.55
|
|
Net realized and unrealized gains (losses)
|
|
3.76
|
|
|
2.97
|
|
|
3.37
|
|
|
1.49
|
|
|
(5.75
|
)
|
Net increase (decrease) from operations
|
|
4.02
|
|
|
3.21
|
|
|
3.71
|
|
|
1.90
|
|
|
(5.20
|
)
|
Dividends from net investment income
|
|
(0.24
|
)
|
|
(0.39
|
)
|
|
(0.50
|
)
|
|
(0.68
|
)
|
|
(0.78
|
)
|
Net asset value, end of year
|
|
$34.32
|
|
|
$30.54
|
|
|
$27.72
|
|
|
$24.51
|
|
|
$23.29
|
|
Total investment
return
2
|
|
13.24
|
%
|
|
11.74
|
%
|
|
15.17
|
%
|
|
8.13
|
%
|
|
(17.16
|
)%
|
Ratios to average net assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses before fee waivers
|
|
0.75
|
%
|
|
0.75
|
%
|
|
0.73
|
%
|
|
0.70
|
%
|
|
0.65
|
%
|
Expenses after fee waivers
|
|
0.75
|
%
|
|
0.75
|
%
|
|
0.73
|
%
|
|
0.70
|
%
|
|
0.65
|
%
|
Net investment income
|
|
0.78
|
%
|
|
0.81
|
%
|
|
1.20
|
%
|
|
1.63
|
%
|
|
2.65
|
%
|
Supplemental data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets, end of year (000s)
|
|
$19,054
|
|
|
$18,911
|
|
|
$19,287
|
|
|
$24,955
|
|
|
$34,630
|
|
Portfolio turnover
|
|
148
|
%
|
|
150
|
%
|
|
157
|
%
|
|
138
|
%
|
|
111
|
%
|
1
Calculated using the
average shares method.
|
2
Total investment
return is calculated assuming a $10,000 investment on the first day of
each year reported, reinvestment of all dividends and other distributions,
if any, at net asset value on the ex-dividend dates, and a sale at net
asset value on the last day of each year reported. The figures do not
include any applicable sales charges or redemption fees; results would be
lower if they were included. Returns do not reflect the deduction of taxes
that a shareholder would pay on Fund distributions or the redemption of
Fund shares.
|
See accompanying notes to financial
statements
|
31
|
UBS U.S. Allocation Fund
Notes to financial statements
Organization
and significant accounting policies
UBS U.S. Allocation Fund (the Fund) is a series of UBS Investment Trust
(the Trust) and is registered with the US Securities and Exchange Commission
(SEC) under the Investment Company Act of 1940 (the 1940 Act), as amended,
as an open-end, diversified management investment company. The Trust was
organized on March 28, 1991, as a business trust under the laws of the
Commonwealth of Massachusetts and currently has one operating series.
The Fund offers Class A, Class C and
Class Y shares. Each class represents interests in the same assets of the Fund,
and the classes are identical except for differences in their sales charge
structures, ongoing service and distribution charges and certain transfer agency
and related services expenses. All classes of shares have equal voting
privileges except that Class A and Class C shares each have exclusive voting
rights with respect to their respective service and/or distribution plans. Class
Y shares have no service or distribution plan.
In the normal course of business the
Fund may enter into contracts that contain a variety of representations or that
provide indemnification for certain liabilities. The Funds maximum exposure
under these arrangements is unknown, as this would involve future claims that
may be made against the Fund that have not yet occurred. However, the Fund has
not had such claims or losses through August 31, 2013 pursuant to these
contracts and expects the risk of loss to be remote.
The Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) is the exclusive
reference of authoritative US generally accepted accounting principles (US
GAAP) recognized by the FASB to be applied by nongovernmental entities. Rules
and interpretive releases of the SEC under authority of federal laws are also
sources of authoritative US GAAP for SEC registrants. The Funds financial
statements are prepared in accordance with US GAAP, which may require the use of
management estimates and assumptions. Actual results could differ from those
estimates. The following is a summary of significant accounting
policies:
Valuation of
investments
The Fund
calculates its net asset value on days that the New York Stock Exchange (NYSE)
is open. The Fund calculates net asset value separately for each class as of the
close of regular trading on the NYSE (generally, 4:00 p.m., Eastern time). If
trading on the NYSE is halted for the day before 4:00 p.m., Eastern time, the
Funds net asset value per share will be calculated as of the time trading was
halted.
The Fund calculates its net asset
value based on the current market value, where available, for its portfolio
securities. The Fund normally obtains market values for its investments from
independent pricing sources and broker-dealers. Independent pricing sources may
use reported last sale prices, official market closing prices, current market
quotations or valuations from computerized evaluation systems that derive values
based on comparable investments. An evaluation system incorporates parameters
such as security quality, maturity and coupon, and/or research and evaluation by
its staff, including review of broker-dealer market price quotations, if
available, in determining the valuation of the portfolio investments.
Investments also may be valued based on appraisals derived from information
concerning the investments or similar investments received from recognized
dealers in those holdings.
Investments traded in the
over-the-counter (OTC) market and listed on The NASDAQ Stock Market, Inc.
(NASDAQ) normally are valued at the NASDAQ Official Closing Price. Other OTC
securities are valued at the last bid price on the valuation date available
prior to valuation. Investments which are listed on US and foreign stock
exchanges normally are valued at the market closing price, the last sale price
on the day the securities are valued or, lacking any sales on such day, at the
last available bid price. In cases where investments are traded on more than one
exchange, the investments are valued on the exchange designated as the primary
market by UBS Global Asset Management (Americas) Inc. (UBS Global AM or the
Advisor), the investment advisor of the Fund. UBS Global AM is an indirect
wholly owned asset management subsidiary of UBS AG, an internationally
diversified organization with headquarters in Zurich and Basel, Switzerland and
operations in many areas of the financial services industry. If
UBS U.S. Allocation Fund
Notes to financial statements
a market value is not readily
available from an independent pricing source for a particular security, that
investment
is valued at fair value as determined in good faith by or
under the direction of the Board of Trustees (the Board). Various factors may
be reviewed in order to make a good faith determination of an investments fair
value. These factors include, but are not limited to, the type and cost of the
security; contractual or legal restrictions on resale of the security; relevant
financial or business developments of the issuer; actively traded similar or
related securities; conversion or exchange rights on the security; related
corporate actions; and changes in overall market conditions. If events occur
that materially affect the value of securities (particularly non-US securities)
between the close of trading in those securities and the close of regular
trading on the New York Stock Exchange, these securities are fair
valued.
The amortized cost method of
valuation, which approximates market value, generally is used to value
short-term debt-instruments with 60 days or less remaining to maturity, unless
the Board determines that this does not represent fair value. Investments in
open-end investment companies are valued at the daily closing net asset value of
the respective investment company. Pursuant to the Funds use of the practical
expedient within ASC Topic 820, investments in non-registered investment
companies are also valued at the daily net asset value. Futures contracts are
generally valued at the settlement price established each day on the exchange on
which they are traded. Swaps are marked-to-market daily based upon values from
third party vendors or quotations from market makers to the extent available. In
the event that the market quotations are not readily available or deemed
unreliable, the swap is valued at fair value as determined in good faith by or
under the direction of the Board.
The Board has delegated to the UBS
Global AM Global Valuation Committee (GVC) the responsibility for making fair
value determinations with respect to the Funds holdings. The GVC is comprised
of representatives of management, including members of the investment team. The
GVC provides reports to the Board at each quarterly meeting regarding any
investments that have been fair valued, valued pursuant to standing instructions
approved by the GVC, or where non-vendor pricing sources had been used to make
fair value determinations when sufficient information exists during the prior
quarter. Fair valuation determinations are subject to review at least monthly by
the GVC during scheduled meetings. Pricing decisions, processes, and controls
over fair value determinations are subject to internal and external reviews,
including annual internal compliance reviews and periodic internal audit reviews
of securities valuations.
US GAAP requires disclosure
surrounding the various inputs that are used in determining the value of the
Funds investments. These inputs are summarized into the three broad levels
listed below:
Level 1Unadjusted quoted prices in
active markets for identical investments.
Level 2Other significant observable inputs, including but not limited
to, quoted prices for similar investments, interest rates, prepayment speeds and
credit risks.
Level 3Unobservable inputs
inclusive of the Funds own assumptions in determining the fair value of
investments.
In accordance with the requirements
of US GAAP, a fair value hierarchy has been included near the end of the Funds
Portfolio of investments.
In January 2013, Accounting Standards
Update 2013-01 (ASU 2013-01), Clarifying the Scope of Disclosures about
Offsetting Assets and Liabilities, replaced Accounting Standards Update 2011-11
(ASU 2011-11), Disclosures about Offsetting Assets and Liabilities. ASU
2013-01 is effective for fiscal years beginning on or after January 1, 2013, and
interim periods within those annual periods. ASU 2011-11 was intended to enhance
disclosure requirements on the offsetting of financial assets and liabilities.
ASU 2013-01 limits the scope of the new balance sheet offsetting disclosures to
derivatives, repurchase agreements, and securities lending transactions to the
extent that they are (1) offset in the financial statements or (2) subject to an
enforceable master netting arrangement or similar agreement. Management is
currently evaluating the application of ASU 2013-01 and its impact, if any, on
the Funds financial statements.
UBS U.S. Allocation Fund
Notes to financial statements
The provisions of ASC Topic 815
Derivatives and Hedging (ASC Topic 815) require qualitative disclosures
about objectives and strategies for using derivatives, quantitative disclosures
about fair value amounts of gains and losses on derivative instruments and
disclosures about credit-risk related contingent features in derivative
agreements. Since investment companies value their derivatives at fair value and
recognize changes in fair value through the Statement of operations, they do not
qualify for hedge accounting under ASC Topic 815. Accordingly, even though a
Funds investments in derivatives may represent economic hedges, they are
considered to be non-hedge transactions for purposes of disclosure under ASC
Topic 815. ASC Topic 815 requires (1) objectives for using derivative
instruments be disclosed in terms of underlying risk and accounting designation,
(2) the fair values of derivative instruments and their gains and losses be
disclosed in a tabular format, and (3) information be disclosed about
credit-risk contingent features of derivatives contracts. The Fund may enter
into derivative contracts that may contain credit-risk related contingent
features that could be triggered subject to certain circumstances. Such
circumstances include agreed upon net asset value thresholds. If triggered, the
derivative counterparty could request additional cash margin and/or terminate
the derivative contract. Details of this disclosure can be found below as well
as in the Portfolio of investments. The Advisor is not aware of any additional
credit-risk contingent features on derivative contracts held by the Fund (other
than those described earlier). The volume of derivatives that is presented in
the Portfolio of investments of the Fund is consistent with the derivative
activity during the year ended August 31, 2013.
At August 31, 2013, the Fund had the
following derivatives categorized by underlying risk:
Asset derivatives
|
|
Interest
rate risk
|
|
Equity
risk
|
|
Total
|
Futures contracts
1
|
|
$19,245
|
|
|
$
|
1,061,788
|
|
|
$
|
1,081,033
|
|
Liability
derivatives
|
|
Interest
rate risk
|
|
Equity
risk
|
|
Total
|
Futures contracts
1
|
$
|
(10,240
|
)
|
|
$
|
(481,254
|
)
|
|
$
|
(491,494
|
)
|
1
Futures contracts
are reported in the table above using the cumulative appreciation
(depreciation) as detailed in the futures contract table at the end of the
Portfolio of investments, but only the variation margin to be received or
paid, if any, is reported within the Statement of assets and
liabilities.
|
Net realized and unrealized gains
(losses) from derivative instruments during the year ended August 31, 2013, were
as follows:
|
Interest
rate risk
|
|
Equity
risk
|
|
Total
|
Net
realized gain (loss)
2
|
|
|
|
|
|
|
|
|
|
|
|
Futures contracts
|
$
|
(236,841
|
)
|
|
$
|
7,111,792
|
|
|
$
|
6,874,951
|
|
Swap agreements
|
|
352,272
|
|
|
|
|
|
|
|
352,272
|
|
Options purchased
3
|
|
|
|
|
|
(606,608
|
)
|
|
|
(606,608
|
)
|
Total net realized gain
|
$
|
115,431
|
|
|
$
|
6,505,184
|
|
|
$
|
6,620,615
|
|
Net change in unrealized
appreciation/depreciation
4
|
|
|
|
|
|
|
|
|
|
|
|
Futures contracts
|
$
|
(65,847
|
)
|
|
$
|
136,061
|
|
|
$
|
70,214
|
|
Swap agreements
|
|
31,867
|
|
|
|
|
|
|
|
31,867
|
|
Total net change in unrealized
appreciation/depreciation
|
$
|
(33,980
|
)
|
|
$
|
136,061
|
|
|
$
|
102,081
|
|
2
The net realized
gains are shown in the Statement of operations in net realized gains from
futures and swaps.
|
3
Net realized loss is
included in net realized gains from investments in unaffiliated issuers in
the Statement of operations.
|
4
The net change in
unrealized appreciation/depreciation is shown in the Statement of
operations in net change in unrealized appreciation/depreciation of
futures and swaps.
|
UBS U.S. Allocation Fund
Notes to financial statements
Repurchase
agreements
The Fund may
purchase securities or other obligations from a bank or securities dealer (or
its affiliate), subject to the sellers agreement to repurchase them at an
agreed upon date (or upon demand) and price. The Fund maintains custody of the
underlying obligations prior to their repurchase, either through its regular
custodian or through a special tri-party custodian or sub-custodian that
maintains a separate account for both the Fund and its counterparty. The
underlying collateral is valued daily in an effort to ensure that the value,
including accrued interest, is at least equal to the repurchase price. In the
event of default of the obligation to repurchase, the Fund generally has the
right to liquidate the collateral and apply the proceeds in satisfaction of the
obligation. Repurchase agreements involving obligations other than US government
securities (such as commercial paper, corporate bonds, equities and mortgage
loans) may be subject to special risks and may not have the benefit of certain
protections in the event of counterparty insolvency. If the seller (or sellers
guarantor, if any) becomes insolvent, the Fund may suffer delays, costs and
possible losses in connection with the disposition or retention of the
collateral. Under certain circumstances, in the event of default or bankruptcy
by the other party to the agreement, realization and/or retention of the
collateral may be subject to legal proceedings. The Fund may participate in
joint repurchase agreement transactions with other funds managed or advised by
UBS Global AM in accordance with an exemptive order granted by the SEC pursuant
to Section 17(d) of the Act and Rule 17d-1 thereunder.
Under certain circumstances, the Fund
may engage in a repurchase agreement transaction with a yield of zero in order
to invest cash amounts remaining in its portfolio at the end of the day in order
to avoid having the Fund assessed a fee for uninvested cash held in a business
account at a bank.
Restricted
securities
The Fund may invest
in securities that are subject to legal or contractual restrictions on resale.
These securities generally may be resold in transactions exempt from
registration or to the public if the securities are registered. Disposal of
these securities may involve time-consuming negotiations and expense, and prompt
sale at an acceptable price may be difficult. Information regarding restricted
securities, if any, is included at the end of the Funds Portfolio of
investments.
Investment
transactions, investment income and expenses
Investment transactions are recorded on the trade date.
Realized gains and losses from investment transactions are calculated using the
identified cost method. Dividend income is recorded net of withholding taxes on
the ex-dividend date (ex-date). Interest income is recorded on an accrual
basis. Discounts are accreted and premiums are amortized as adjustments to
interest income and the identified cost of investments.
Income, expenses (excluding
class-specific expenses) and realized/unrealized gains/losses are allocated
proportionately to each class of shares based upon the relative net asset value
of outstanding shares (or the value of dividend eligible shares, as appropriate)
of each class at the beginning of the day (after adjusting for current capital
share activity of the respective classes). Class-specific expenses are charged
directly to the applicable class of shares.
Securities
traded on to-be-announced basis
The Fund may from time to time purchase securities on a to-be-announced
(TBA) basis. In a TBA transaction, the Fund commits to purchasing or selling
securities for which all specific information is not yet known at the time of
the trade, particularly the face amount and maturity date of the underlying
security transactions. Securities purchased on a TBA basis are not settled until
they are delivered to the Fund, normally 15 to 45 days later. Beginning on the
date the Fund enters into a TBA transaction, cash, US government securities or
other liquid securities are segregated in an amount equal in value to the
purchase price of the TBA security. These transactions are subject to market
fluctuations, and their current value is determined in the same manner as for
other securities.
UBS U.S. Allocation Fund
Notes to financial statements
Purchased
options
The Fund may purchase
put and call options. Purchasing call options tends to increase exposure to the
underlying instrument. Purchasing put options tends to decrease exposure to the
underlying instrument. The Fund pays a premium which is included on the
Statement of assets and liabilities as an investment and subsequently marked to
market to reflect the current value of the option. Premiums paid for purchasing
options which expire are treated as realized losses. The risk associated with
purchasing put and call options is limited to the premium paid. Premiums paid
for purchasing options which are exercised or closed are added to the amounts
paid or offset against the proceeds on the underlying future, security or
currency transaction to determine the realized gain or loss. Purchased options
are shown as fund holdings within the Portfolio of investments and are included
in the Statement of assets and liabilities in investments in unaffiliated
securities, at value.
Futures
contracts
The Fund may use
futures contracts as part of its investment strategy, for hedging purposes to
adjust exposure to US and foreign markets in connection with a reallocation of
the Funds assets or to manage the average duration of the Fund. In addition,
the Fund may purchase or sell futures contracts or purchase options thereon to
increase or reduce its exposure to an asset class without purchasing or selling
the underlying securities, either as a hedge or to enhance performance. Using
futures contracts involves various market risks, including interest rate and
equity risk. Risks of entering into futures contracts include the possibility
that there may be an illiquid market or that a change in the value of the
contract may not correlate with changes in the value of the underlying
securities. To the extent that market prices move in an unexpected direction,
there is a risk that the Fund will not achieve the anticipated benefits of the
futures contract or may realize a loss.
Upon entering into a futures
contract, the Fund is required to deliver to a broker an amount of cash and/or
government securities equal to a certain percentage of the contract amount. This
amount is known as the initial margin. Subsequent payments, known as
variation margin, generally are made or received by the Fund each day,
depending on the fluctuations in the value of the underlying futures contracts,
except that in the case of certain futures contracts payments may be made or
received at settlement. Such variation margin is recorded for financial
statement purposes on a daily basis as an unrealized gain or loss on futures
until the futures contract is closed, at which time the net gain or loss is
reclassified to realized gain or loss on futures.
Swap
agreements
The Fund may enter
into interest rate swap agreements. This type of swap is an agreement that
obligates two parties to exchange a series of cash flows at specified intervals
based upon or calculated by reference to a specified interest rate(s) for a
specified amount. The payment flows are usually netted against each other, with
the difference being paid by one party to the other.
Risks may arise as a result of the
failure of the counterparty to the swap agreement to comply with the terms of
the agreement. The loss incurred by the failure of a counterparty is generally
limited to the net interest payment to be received by the Fund. Therefore, the
Fund considers the creditworthiness of the counterparty to a swap agreement in
evaluating potential credit risk.
The Fund accrues for interim payments
on swap agreements on a daily basis, with the net amount recorded within swap
agreements on the Statement of assets and liabilities. Once interim payments are
settled in cash, the net amount is recorded as realized gain/loss on swaps, in
addition to realized gain/loss recorded upon the termination of swap contracts
on the Statement of operations. Fluctuations in the value of interest rate swap
agreements are recorded for financial statement purposes as unrealized
appreciation or depreciation of swaps within the Statement of
operations.
UBS U.S. Allocation Fund
Notes to financial statements
Inflation swap agreements are used to
hedge inflation risk by transferring inflation risk from one party to another
through an exchange of cash flows. In an inflation swap, one party pays a fixed
rate on a notional principal amount while the other party pays a floating rate
linked to an inflation index on that same notional amount. The party paying the
floating rate pays the inflation adjusted rate multiplied by the notional
principal amount. If the average inflation rate over the term of the swap is the
same as the fixed rate of the swap, the two legs will have the same value and
the swap will break even.
Dividends and
distributions
Dividends and
distributions to shareholders are recorded on the ex-dividend date. The
amounts
of dividends and distributions are determined in accordance with federal
income tax regulations, which may differ from US GAAP. These book/tax
differences are either considered temporary or permanent in nature. To the
extent these differences are permanent in nature, such amounts are reclassified
within the capital accounts based on their federal tax-basis treatment;
temporary differences do not require reclassification.
Concentration
of risk
Investing in
securities of foreign issuers and currency transactions may involve certain
considerations and risks not typically associated with investments in the United
States. These risks include revaluation of currencies, adverse fluctuations in
foreign currency values and possible adverse political, social and economic
developments, including those particular to a specific industry, country or
region, which could cause the securities and their markets to be less liquid and
prices more volatile than those of comparable US companies and US government
securities. These risks are greater with respect to securities of issuers
located in emerging market countries. The ability of the issuers of the debt
securities held by the Fund to meet their obligations may be affected by
economic developments, including those particular to a specific industry,
country, state or region.
Investment
advisor and administrator fees and other transactions with
affiliates
The Board has
approved an Investment Advisory and Administration Contract (the Advisory
Contract), under which UBS Global AM serves as investment advisor and
administrator of the Fund. In accordance with the Advisory Contract, the Fund is
to pay UBS Global AM an investment advisory and administration fee, which is to
be accrued daily and paid monthly, at an annual rate of 0.50% of the Funds
average daily net assets up to $250 million and 0.45% thereafter.
UBS Global AM has agreed to
permanently reduce its advisory and administration fee based on the Funds
average daily net assets so that it is assessed as follows: $0 to $250 million
0.50%; in excess of $250 million up to $500 million 0.45%; in excess of $500
million up to $2 billion 0.40%; and over $2 billion 0.35%. Accordingly, for
the year ended August 31, 2013, UBS Global AM did not waive any investment
advisory and administration fees. At August 31, 2013, the Fund owed UBS Global
AM $109,883 for investment advisory and administration fees.
UBS Global AM has contractually
undertaken to waive fees/reimburse a portion of the Funds expenses, when
necessary, to maintain the total annual operating expenses (excluding (1)
dividend expense, borrowing costs and interest expense relating to short sales,
and (2) investments in other investment companies, interest, taxes, brokerage
commissions and extraordinary expenses, if any) of Class A, Class C and Class Y
shares at a level not to exceed 1.15%, 1.90% and 0.90%, respectively through
December 31, 2013. The Fund will repay UBS Global AM for any previously waived
fees/reimbursed expenses during the three-year period following August 31, 2013,
to the extent that operating expenses (with certain exclusions such as dividend
expense, borrowing costs, and interest expense relating to short sales, and
interest, taxes, brokerage commissions and extraordinary expenses, if any) are
otherwise below the expense caps in effect at the time the fees or expenses were
waived/reimbursed. For the year ended August 31, 2013, the Fund had no fee
waivers/expense reimbursements subject to repayment.
UBS U.S. Allocation Fund
Notes to financial statements
For the year ended August 31, 2013,
the Fund paid $314 in brokerage commissions to UBS Securities LLC, an indirect
wholly owned subsidiary of UBS AG, for transactions executed on behalf of the
Fund.
The Fund may invest in certain
affiliated investment companies also advised or managed by the Advisor.
Investments in affiliated investment companies for the year ended August 31,
2013 were as follows:
Affiliated
investment
company
|
|
Value at
08/31/12
|
|
Purchases
during the
year
ended
08/31/13
|
|
Sales
during the
year
ended
08/31/13
|
|
Net
realized
gain
|
|
Change
in
net
unrealized
appreciation
|
|
Value at
08/31/13
|
UBS Credit
Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
Relationship Fund
|
|
$11,086,530
|
|
$
|
|
$10,840,271
|
|
$1,793,352
|
|
$(2,039,611)
|
|
$
|
Under normal conditions, the Fund
invests cash collateral from securities lending activities into an affiliated
private money market fund, UBS Private Money Market Fund LLC (Private Money
Market), which operates in compliance with most of the substantive provisions
of Rule 2a-7 of the 1940 Act. Private Money Market is managed by UBS Global AM
and is currently offered as a cash management option to mutual funds and certain
other accounts managed by the Funds investment manager. UBS Global AM acts as
managing member and receives a management fee from Private Money Market payable
monthly in arrears at the annual rate of 0.10% of Private Money Markets average
daily members equity, minus the aggregate operating expenses of, and incurred
by, Private Money Market during each such related month, not including
investment expenses (including brokerage commissions, taxes, interest charges
and other costs with respect to transactions in securities) and extraordinary
expenses including litigation expenses, if any. UBS Global AM may, in its sole
discretion, waive all or any portion of the management fee to which it may be
entitled from time to time in order to maintain operating expenses or net yields
at a certain level. Distributions received from Private Money Market, if any,
net of fee rebates paid to borrowers, would be reflected as securities lending
income in the Statement of operations.
Amounts relating to the investment
for the year ended August 31, 2013, were as follows:
|
|
Value at
08/31/12
|
|
Purchases
during the
year
ended
08/31/13
|
|
Sales
during the
year
ended
08/31/13
|
|
Value at
08/31/13
|
|
Net income
earned
|
UBS Private Money Market Fund
LLC
|
|
$5,655,123
|
|
$46,145,449
|
|
$46,885,193
|
|
$4,915,379
|
|
$2,250
|
Additional
information regarding compensation to affiliate of a board
member
Professor Meyer
Feldberg serves as a senior advisor to Morgan Stanley, a financial services firm
with which the Fund may conduct transactions, resulting in him being an
interested trustee of the Fund. The Fund has been informed that Professor
Feldbergs role at Morgan Stanley does not involve matters directly affecting
any UBS funds. Portfolio transactions are executed through Morgan Stanley based
on that firms ability to provide best execution of the transactions. During the
year ended August 31, 2013, the Fund paid brokerage commissions to Morgan
Stanley in the amount of $11,473.
During the year ended August 31,
2013, the Fund purchased and sold certain securities (e.g., fixed income
securities) in principal trades with Morgan Stanley, having an aggregate value
of $38,619,172. Morgan Stanley received compensation in connection with these
trades, which may have been in the form of a mark-up or mark-down of the
price of the securities, a fee from the issuer for maintaining a commercial
paper program, or some other form of compensation. Although the precise amount
of this compensation is not generally known by the Funds investment manager, it
is believed that under normal circumstances it represents a small portion of the
total value of the transactions.
UBS U.S. Allocation Fund
Notes to financial statements
Service and
distribution plans
UBS Global Asset
Management (US) Inc. (UBS Global AM (US)) is the principal underwriter of the
Funds shares. Under separate plans of service and/or distribution pertaining to
Class A and Class C shares, the Fund pays UBS Global AM (US) monthly service
fees at an annual rate of 0.25% of the average daily net assets of Class A and
Class C shares and monthly distribution fees at the annual rate of 0.75% of the
average daily net assets of Class C shares. At August 31, 2013, the Fund owed
UBS Global AM (US) $95,665 for service and distribution fees.
UBS Global AM (US) also receives the
proceeds of the initial sales charges paid by shareholders upon the purchase of
Class A shares and the contingent deferred sales charges paid by shareholders
upon certain redemptions of Class A and Class C shares. UBS Global AM (US) has
informed the Fund that for the year ended August 31, 2013, it earned $8,052 in
initial sales charges on Class A shares and $2,424 in deferred sales charges on
Class A and Class C shares.
Transfer agency related
services
UBS Financial Services Inc.
provides certain services to the Fund pursuant to a delegation of authority from
BNY Mellon Investment Servicing (US) Inc. (BNY Mellon), the Funds transfer
agent, and is compensated for these services by BNY Mellon, not the Fund.
For the year ended August 31, 2013,
UBS Financial Services Inc. received from BNY Mellon, not the Fund, $113,792 of
the total transfer agency and related service fees paid by the Fund to BNY
Mellon.
Securities
lending
The Fund may lend securities
up to 33¹/³% of its total assets to qualified broker-dealers or institutional
investors. The loans are secured at all times by cash, US government securities
or irrevocable letters of credit in an amount at least equal to the market value
of the securities loaned, plus accrued interest and dividends, determined on a
daily basis and adjusted accordingly. The Fund will regain ownership of loaned
securities to exercise certain beneficial rights; however, the Fund may bear the
risk of delay in recovery of, or even loss of rights in, the securities loaned
should the borrower fail financially. The Fund receives compensation for lending
its securities from interest or dividends earned on the cash, US government
securities or irrevocable letters of credit held as collateral, net of fee
rebates paid to the borrower plus reasonable administrative and custody fees.
State Street Bank and Trust Company serves as the Funds lending
agent.
At August 31, 2013, the Fund had
securities on loan, cash collateral and non-cash collateral as
follows:
Value of securities
on loan
|
|
Cash collateral
|
|
Non-cash collateral*
|
|
Total collateral
|
|
Security types held as non-cash
collateral
|
$6,224,158
|
|
$4,915,379
|
|
$1,492,202
|
|
$6,407,581
|
|
US Treasury Notes and US Treasury
Bills
|
*
|
These securities are held for the benefit of the
Fund at the Funds custodian. The Fund cannot repledge or resell this
collateral. As such, this collateral is excluded from the Statement of
assets and liabilities.
|
Bank line of
credit
The Fund participates with
other funds managed or advised by UBS Global AM in a $100 million committed
credit facility with State Street Bank and Trust Company (Committed Credit
Facility), to be utilized for temporary financing until the settlement of sales
or purchases of portfolio securities, the repurchase or redemption of shares of
the Fund at the request of shareholders and other temporary or emergency
purposes. Under the Committed Credit Facility arrangement, the Fund has agreed
to pay a commitment fee, pro rata, based on the relative asset size of the funds
in the Committed Credit Facility. The Fund borrows at prevailing rates in effect
at the time of borrowings. The Fund did not borrow under the Committed Credit
Facility during the year ended August 31, 2013.
UBS U.S. Allocation Fund
Notes to financial statements
Purchases and sales of
securities
For the year ended August
31, 2013, aggregate purchases and sales of portfolio securities, excluding
short-term securities and US Government securities, were $86,555,776 and
$172,645,890, respectively.
For the year ended August 31, 2013,
aggregate purchases and sales of US Government securities, excluding short-term
securities, were $203,079,321 and $200,349,853, respectively.
Shares of beneficial
interest
There is an unlimited amount
of $0.001 par value shares of beneficial interest authorized. Transactions in
shares of beneficial interest were as follows:
For
the year ended
|
|
Class A
|
|
Class C
|
|
Class Y
|
August 31, 2013
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
Shares sold
|
|
32,066
|
|
|
$
|
1,027,250
|
|
|
8,488
|
|
|
$
|
268,477
|
|
|
18,505
|
|
|
$
|
584,781
|
|
Shares repurchased
|
|
(871,737
|
)
|
|
|
(27,701,138
|
)
|
|
(308,557
|
)
|
|
|
(9,718,656
|
)
|
|
(87,065
|
)
|
|
|
(2,769,423
|
)
|
Dividends reinvested
|
|
25,133
|
|
|
|
767,553
|
|
|
|
|
|
|
|
|
|
4,498
|
|
|
|
138,982
|
|
Net decrease
|
|
(814,538
|
)
|
|
$
|
(25,906,335
|
)
|
|
(300,069
|
)
|
|
$
|
(9,450,179
|
)
|
|
(64,062
|
)
|
|
$
|
(2,045,660
|
)
|
For
the year ended
|
|
Class A
|
|
Class B
1
|
August 31, 2012
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
Shares sold
|
|
71,125
|
|
|
$
|
2,018,604
|
|
|
|
|
|
$
|
|
|
Shares repurchased
|
|
(976,736
|
)
|
|
|
(27,867,821
|
)
|
|
(1,404
|
)
|
|
|
(39,442
|
)
|
Shares converted from Class B to Class
A
|
|
54,541
|
|
|
|
1,608,580
|
|
|
(54,076
|
)
|
|
|
(1,608,580
|
)
|
Dividends reinvested
|
|
61,490
|
|
|
|
1,655,927
|
|
|
|
|
|
|
|
|
Net decrease
|
|
(789,580
|
)
|
|
$
|
(22,584,710
|
)
|
|
(55,480
|
)
|
|
$
|
(1,648,022
|
)
|
|
|
|
Class C
|
|
Class Y
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
Shares sold
|
|
17,397
|
|
|
$
|
482,487
|
|
|
9,380
|
|
|
$
|
282,950
|
|
Shares repurchased
|
|
(434,951
|
)
|
|
|
(12,250,080
|
)
|
|
(95,338
|
)
|
|
|
(2,769,203
|
)
|
Dividends reinvested
|
|
5,681
|
|
|
|
151,047
|
|
|
9,475
|
|
|
|
258,106
|
|
Net decrease
|
|
(411,873
|
)
|
|
$
|
(11,616,546
|
)
|
|
(76,483
|
)
|
|
$
|
(2,228,147
|
)
|
1
|
Effective March 1, 2012 all outstanding Class B
shares converted to Class A shares.
|
Redemption
fees
Each class of the Fund will
impose a 1% redemption fee on shares sold or exchanged within 90 days of their
purchase date, subject to limited exemptions as noted in the prospectus. This
amount is paid to the Fund. The redemption fees, if any, earned by the Fund are
disclosed in the Statement of changes in net assets. For the year ended August
31, 2013, redemption fees for each class of the Fund represent less than $0.005
per share.
Federal tax
status
The Fund intends to distribute
substantially all of its income and to comply with the other requirements of the
Internal Revenue Code applicable to regulated investment companies. Accordingly,
no provision for federal income taxes is required. In addition, by distributing
during each calendar year substantially all of its net investment income, net
realized capital gains and certain other amounts, if any, the Fund intends not
to be subject to a federal excise tax.
UBS U.S. Allocation Fund
Notes to financial statements
The tax character of distributions
paid during the fiscal years ended August 31, 2013 and August 31, 2012 were as
follows:
Distributions paid from:
|
|
2013
|
|
2012
|
Ordinary Income
|
|
$996,931
|
|
$2,278,911
|
At August 31, 2013, the components of
accumulated deficit on a tax basis were as follows:
Undistributed ordinary income
|
|
$
|
975,411
|
|
Accumulated realized capital and other losses
|
|
|
(77,579,739
|
)
|
Net unrealized appreciation of
investments
|
|
|
13,975,520
|
|
Total accumulated deficit
|
|
$
|
(62,628,808
|
)
|
The differences between book-basis
and tax-basis unrealized appreciation/depreciation is attributable primarily to
the tax deferral of losses on wash sales
and the tax treatment of certain
derivative instruments.
To reflect reclassifications arising
from permanent book/tax differences for the year ending August 31, 2013,
accumulated undistributed net investment income was increased by $133,069, and
accumulated net realized loss was increased by $133,069. These differences are
primarily due to income reallocation from real estate investment
trusts
and paydown reclasses.
Under the Regulated Investment
Company Modernization Act of 2010 (the Act), net capital losses recognized by
the Fund
after December 31, 2010, may be carried forward indefinitely, and retain
their character as short-term and/or long-term losses. The Act requires that
post-enactment net capital losses be used before pre-enactment net capital
losses.
At August 31, 2013, the Fund had a
pre-enactment net capital loss carryforward of $77,579,739. This pre-enactment
capital loss carryforward is available as a reduction, to the extent provided in
the regulations, of any future net realized capital gains and the full amount
will expire in 2018. To the extent that such losses are used to offset future
net realized capital gains, it is probable these gains will not be distributed.
During the current fiscal year, the Fund utilized $30,841,793 of capital loss
carryforwards to offset current year realized gains.
As of and during the year ended
August 31, 2013, the Fund
did not have any liabilities for any
uncertain tax positions. The Funds recognize interest and penalties, if any,
related to uncertain tax positions as income tax expense in the Statements of
operations. During the year ended August 31, 2013, the Fund
did not incur
any interest or penalties.
Each of the tax years in the four
year period ended August 31, 2013, remains subject to examination by the
Internal Revenue Service and state taxing authorities.
UBS U.S. Allocation Fund
Report of Ernst & Young LLP, independent
registered public
accounting firm
The Board of Trustees and
Shareholders of
UBS U.S. Allocation Fund
We have audited the accompanying
statement of assets and liabilities, including the portfolio of investments, of
UBS U.S. Allocation Fund (the sole series comprising UBS Investment Trust) (the
Fund) as of August 31, 2013, and the related statement of operations for the
year then ended, the statement of changes in net assets for each of the two
years in the period then ended, and the financial highlights for each of the
five years in the period then ended. These financial statements and financial
highlights are the responsibility of the Funds management. Our responsibility
is to express an opinion on these financial statements and financial highlights
based on our audits.
We conducted our audits in accordance
with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements and financial
highlights are free of material misstatement. We were not engaged to perform an
audit of the Funds internal control over financial reporting. Our audits
included consideration of internal control over financial reporting as a basis
for designing audit procedures that are appropriate in the circumstances, but
not for the purpose of expressing an opinion on the effectiveness of the Funds
internal control over financial reporting. Accordingly, we express no such
opinion. An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements and financial
highlights, assessing the accounting principles used and significant estimates
made by management and evaluating the overall financial statement presentation.
Our procedures included confirmation of securities owned as of August 31, 2013,
by correspondence with the custodian and others, or by other appropriate
auditing procedures where replies from others were not received. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, the financial
statements and financial highlights referred to above present fairly, in all
material respects, the financial position of UBS U.S. Allocation Fund at August
31, 2013, the results of its operations for the year then ended, the changes in
its net assets for each of the two years in the period then ended, and the
financial highlights for each of the five years in the period then ended, in
conformity with U.S. generally accepted accounting principles.
New York, New York
October 29,
2013
UBS U.S. Allocation Fund
General information (unaudited)
Quarterly Form N-Q
portfolio schedule
The Fund will file
its complete schedule of portfolio holdings with the Securities and Exchange
Commission (SEC) for the first and third quarters of each fiscal year on Form
N-Q. The Funds Forms N-Q are available on the SECs Web site at
http://www.sec.gov. The Funds Forms N-Q may be reviewed and copied at the SECs
Public Reference Room in Washington, D.C. Information on the operation of the
SECs Public Reference Room may be obtained by calling 1-800-SEC 0330.
Additionally, you may obtain copies of Forms N-Q from the Fund upon request by
calling 1-800-647 1568.
Proxy voting policies,
procedures and record
You may obtain
a description of the Funds (1) proxy voting policies, (2) proxy voting
procedures and (3) information regarding how the Fund voted any proxies related
to portfolio securities during the most recent 12-month period ended June 30 for
which an SEC filing has been made, without charge, upon request by contacting
the Fund directly at 1-800-647 1568, online on the Funds Web site:
www.ubs.com/ubsglobalam-proxy, or on the EDGAR Database on the SECs Web site
(http://www.sec.gov).
UBS U.S. Allocation Fund
Tax information (unaudited)
We are required by Subchapter M of
the Internal Revenue Code of 1986, as amended, to advise you within 60 days of
the Funds fiscal year end (August 31, 2013) as to the federal tax status of
distributions received by shareholders during such fiscal year. The percentage
of dividends paid that qualify for the dividends received deduction for
corporate shareholders is 100%.
For the fiscal year ended August 31,
2013, certain dividends paid by UBS U.S. Allocation Fund may be subject to a
maximum tax rate of 15%, as provided for by the Jobs and Growth Tax Relief
Reconciliation Act of 2003. Of the distributions paid during the fiscal year,
$996,931 represents the maximum amount that may be considered qualified dividend
income.
Dividends received by tax-exempt
recipients (e.g., IRAs and Keoghs) need not be reported as taxable income. Some
retirement trusts (e.g., corporate, Keogh and 403(b)(7) plans) may need this
information for their annual information reporting.
Since the Funds fiscal year is not
the calendar year, another notification will be sent in respect of calendar year
2013. The second notification, which will reflect the amount to be used by
calendar year taxpayers on their federal income tax returns, will be made in
conjunction with Form 1099 DIV and will be mailed in January 2014. Shareholders
are advised to consult their own tax advisers with respect to the tax
consequences of their investment in the Fund.
UBS U.S. Allocation Fund
Board approval of investment advisory
and
administration agreement (unaudited)
Background
At a meeting of the board of UBS Investment Trust (the
Trust) on July 16-17, 2013, the members of the board, including the trustees
who are not interested persons of the Trust (Independent Trustees), as
defined in the Investment Company Act of 1940, as amended (the 1940 Act),
considered and approved the continuance of the investment advisory and
administration agreement (the Investment Advisory and Administration
Agreement) of the Trust with respect to its series, UBS U.S. Allocation Fund
(the Fund), with UBS Global Asset Management (Americas) Inc. (UBS Global
AM). In preparing for the meeting, the board members had requested and received
extensive information from UBS Global AM to assist them. The board received and
considered a variety of information about UBS Global AM as well as the advisory,
administrative and distribution arrangements for the Fund. Independent Trustees
discussed the materials initially provided by management among themselves on
several occasions prior to the scheduled board meeting, and independent legal
counsel participated in several such discussions. The Independent Trustees also
met in executive session with their independent legal counsel to review the
presentation that had been made to them at the meeting. The Independent Trustees
also received a memorandum from their independent legal counsel discussing the
duties of board members in considering approval of advisory, administration and
distribution agreements.
In its consideration of the approval
of the Investment Advisory and Administration Agreement, the board considered
the following factors:
Nature, extent and quality of the
services under the Investment Advisory and Administration
Agreement
The
board received and considered information regarding the nature, extent and
quality of advisory services provided to the Fund by UBS Global AM under the
Investment Advisory and Administration Agreement during the past year. The board
also considered the nature, extent and quality of administrative, distribution,
and shareholder services performed by UBS Global AM and its affiliates for the
Fund and the resources devoted to, and the record of compliance with, the Funds
compliance policies and procedures. The board noted that it received information
at regular meetings throughout the year regarding the services rendered by UBS
Global AM concerning the management of the Funds affairs and UBS Global AMs
role in coordinating providers of other services to the Fund, including custody,
accounting and transfer agency services. The boards evaluation of the services
provided by UBS Global AM took into account the boards knowledge and
familiarity gained as board members of funds in the UBS New York fund complex,
including the scope and quality of UBS Global AMs investment advisory and other
capabilities and the quality of its administrative and other services. The board
observed that the scope of services provided by UBS Global AM had expanded over
time as a result of regulatory and other developments, including maintaining and
monitoring its own and the Funds expanded compliance programs.
The board had available to it the
qualifications, backgrounds and responsibilities of the senior personnel at UBS
Global AM responsible for the Fund and had previously met with and received
information regarding the persons primarily responsible for the day-to-day
portfolio management of the Fund and recognized that the Funds senior personnel
at UBS Global AM report to the board regularly and that at each regular meeting
the board receives a detailed report on the Funds performance. The board also
considered, based on its knowledge of UBS Global AM and its affiliates, the
financial resources available to UBS Global AM and its parent organization, UBS
AG. In that regard, the board received extensive financial information regarding
UBS Global AM and noted that it was a wholly owned, indirect subsidiary of one
of the largest financial services firms in the world. It was also noted that UBS
Global AM had approximately $159 billion in assets under management as of March
31, 2013 and was part of the UBS Global Asset Management Division, which had
approximately $632 billion in assets under management worldwide as of March 31,
2013. The board was also cognizant of, and considered, the regulatory and
litigation actions and investigations occurring in the past few years involving
UBS AG, UBS Global AM and certain of their affiliates.
The board concluded that, overall, it
was satisfied with the nature, extent and quality of services provided (and
expected to be provided) to the Fund under the Investment Advisory and
Administration Agreement.
UBS U.S. Allocation Fund
Board approval of investment advisory
and
administration agreement (unaudited)
Advisory fees and expense
ratios
The board reviewed and considered
the contractual management fee (the Contractual Management Fee) payable by the
Fund to UBS Global AM in light of the nature, extent and quality of the advisory
and administrative services provided by UBS Global AM. The board also reviewed
and considered the written agreement between UBS Global AM and the Fund, which
is separate from UBS Global AMs investment advisory agreement with the Fund,
whereby UBS Global AM has agreed to permanently reduce its management fee based
on the Funds average daily net assets, which is discussed in more detail in the
Economies of Scale section, and considered the actual fee rate (after taking
this agreement into account) (the Actual Management Fee). Additionally, the
board received and considered information comparing the Funds Contractual
Management Fee, Actual Management Fee and overall expenses with those of funds
in a group of funds selected and provided by Lipper, Inc. (Lipper), an
independent provider of investment company data (the Expense
Group).
In addition, pursuant to a written
fee waiver/expense reimbursement agreement, UBS Global AM is contractually
obligated to waive its management fees and/or reimburse the Fund so that the
Funds ordinary total annual operating expenses through December 31, 2013
(excluding dividend expense, borrowing costs, and interest expense relating to
short sales, and investments in other investment companies, interest, taxes,
brokerage commissions and extraordinary expenses) would not exceed 1.15% for
Class A shares, 1.90% for Class C shares and 0.90% for Class Y shares. The board
also considered that the Fund has agreed to repay UBS Global AM for those waived
fees and/or reimbursed expenses if the Fund can do so over the following three
fiscal years without causing its expenses in any of those years to exceed the
expense caps.
In connection with its consideration
of the Funds management fees, the board also received information on UBS Global
AMs standard institutional account fees for accounts of a similar investment
type to the Fund. The board noted managements explanation that comparisons with
such accounts may be of limited relevance given the different structures and
regulatory requirements of mutual funds versus such accounts and the differences
in the levels of services required by mutual funds and such accounts. The board
also received information on fees charged to other mutual funds managed by UBS
Global AM.
The comparative Lipper information
showed that the Funds Contractual Management Fee, Actual Management Fee and
total expenses were in the first quintile in the Funds Expense Group for the
comparison periods utilized in the Lipper report. (The first quintile represents
that 20% of the funds in the Expense Group with the lowest fees or expenses, as
applicable, and the fifth quintile represents that 20% of the funds in the
Expense Group with the highest fees or expenses, as applicable.)
In light of the foregoing, the board
determined that the management fee was reasonable in light of the nature, extent
and quality of services provided to the Fund under the Investment Advisory and
Administration Agreement.
Fund performance
The board received and considered (a) annualized total
return information of the Fund compared to other funds (the Performance
Universe) selected by Lipper over the one-, three-, five-, ten-year and since
inception periods ended April 30, 2013 and (b) annualized performance
information for each year in the ten-year period ended April 30, 2013. The board
was provided with a description of the methodology Lipper used to determine the
similarity of the Fund with the funds included in its Performance Universe. The
board also noted that it had received information throughout the year at
periodic intervals with respect to the Funds performance, including with
respect to its benchmark index.
The comparative Lipper information
showed that the Funds performance was in the second quintile for the one- and
three-year periods, in the third quintile for the five-year period and since
inception and in the fourth quintile for the ten-year period. (The first
quintile represents that 20% of the funds in the Performance Universe with the
best relative performance, and the fifth quintile represents that 20% of the
funds in the Performance Universe
UBS U.S. Allocation Fund
Board approval of investment advisory
and
administration agreement (unaudited)
with the worst relative performance.)
Management noted the improved performance of the Fund over the recent periods.
Based on its review of the Fund and managements presentation, the board
concluded that the Funds investment performance was acceptable.
Advisor
profitability
The board received and
considered a profitability analysis of UBS Global AM and its affiliates in
providing services to the Fund. The board also received profitability
information with respect to the UBS New York fund complex as a whole. UBS Global
AMs profitability was considered not excessive in light of the nature, extent
and quality of the services provided to the Fund.
Economies of
scale
The board received and considered
information from management regarding whether UBS Global AM has achieved
economies of scale with respect to the management of the Fund, whether the Fund
has appropriately benefited from any economies of scale, and whether there is
potential for realization of further economies of scale for the Fund. The board
considered whether economies of scale in the provision of services to the Fund
were being passed along to the shareholders. The board noted that the Funds
Contractual Management Fee contained a single breakpoint and that the Funds
assets exceeded the breakpoint as of April 30, 2013.
While the Funds Contractual
Management Fee contained a single breakpoint, the board recognized that the Fund
had entered into a separate agreement with UBS Global AM, whereby UBS Global AM
agreed to permanently reduce its Contractual Management Fee by utilizing several
additional breakpoints based on the Funds average daily net assets, thereby
achieving the same effect as if the Contractual Management Fee contained
multiple breakpoints.
Generally, in light of UBS Global
AMs profitability data and the Contractual Management Fee and Actual
Management Fee currently in place, the board
believed that UBS Global AMs sharing of current economies of scale with the
Fund was acceptable.
Other benefits to UBS Global
AM
The board considered other benefits
received by UBS Global AM and its affiliates as a result of its relationship
with the Fund, including the opportunity to offer additional products and
services to Fund shareholders.
In light of the costs of providing
investment advisory, administrative and other services to the Fund and UBS
Global AMs ongoing commitment to the Fund, the profits and other ancillary
benefits that UBS Global AM and its affiliates received were considered
reasonable.
In light of all of the foregoing, the
board approved the Investment Advisory and Administration Agreement. In making
its decision, the board identified no single factor as being determinative in
approving the Investment Advisory and Administration Agreement. The Independent
Trustees were advised by separate independent legal counsel throughout the
process. The board discussed the proposed continuance of the Investment Advisory
and Administration Agreement in private sessions with their independent legal
counsel at which no representatives of UBS Global AM were present.
UBS U.S. Allocation Fund
Supplemental information (unaudited)